BioVentrix Revivent TC™ System Clinical Study
Summary
- Eligibility
- for people ages 18-100 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Vaikom Mahadevan
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Vaikom Mahadevan
Dr. Vaikom S Mahadevan joined UCSF from the UK in July 2014 as Director of Structural and Adult Congenital cardiac Interventions and the Wiliam W Parmley Endowed Chair in Cardiology and Associate Professor of Medicine. Following completion of his intital medical training in Stanley Medical College in India Dr. Mahadevan did his higher Internal Medicine and Cardiology training …
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioVentrix
- Links
- Sponsor Web Site
- ID
- NCT02931240
- Phase
- Phase 2/3 Research Study
- Study Type
- Interventional
- Participants
- Expecting 126 study participants
- Last Updated